Search Results for 'median cancer'
median cancer published presentations and documents on DocSlides.
Malawi Cancer Consortium Overview
by min-jolicoeur
Satish Gopal MD MPH. University . of Malawi Colle...
Sipuleucel -T Survival Benefit
by calandra-battersby
Sipuleucel. -T was approved based on HR of 0.775 ...
Genomic analysis of circulating tumor DNA in 3,334 patients with advanced prostate cancer to identi
by williams
Foundation Medicine. ctDNA. is good information f...
Complex Cancer Late Effects Rehabilitation Service
by OneAndOnly
(. CCLERS) . Complex Cancer Late Effects Rehabilit...
Disparities in Prostate Cancer Outcomes: Race, Access, and Ancestry
by Soulmate
Andrew J Armstrong MD . ScM. FACP. National Allia...
Significant efforts were made by the Moroccan Ministry of Health as part of the National Cancer Co
by reagan
Patterns of Care (POC) studies are important to . ...
ASCO 2012 Review Gynecologic Cancer
by welnews
Nelson Teng, M.D., Ph.D.. Director, Gynecologic On...
Game Plan Trends in ovarian cancer
by alexa-scheidler
Diagnostic work-up. Treatment. The most commonly ...
Prostate Cancer Screening in 2013: Reports of its Death Are
by min-jolicoeur
Norm D. Smith, M.D.. Associate Professor. Co-Dire...
Managing Breast Cancer in the Genomic Era
by alida-meadow
Leisha. A. . Emens. , M.D., . Ph.D. Associate Pr...
Best of ASCO GU Session Sandy Srinivas.MD
by experimentgoogle
Stanford University. Outline. Abstract #4. :. . I...
Endocrine resistance: molecular pathways and rational development of targeted therapies
by spottletoefacebook
Grazia Arpino. UniversitĂ di Napoli Federico II. ...
Median PFS: 2.6 months (95% CI, 1.7-3.5)
by ceila
Median PFS: 1.4 months (95% CI, 1.2-1.6) . Median ...
Module 3: Chronic Lymphocytic Leukemia
by CottonTails
Josie . Montegaard. , MSN, AGPCNP-BC. Matthew S . ...
Proton Beam Therapy for Liver Cancer is Well Tolerated: Outcomes from the Proton Collaborative Grou
by DancingDragonfly
Michael Chuong, M.D.. 1,2. , Smith . Apisarnthanar...
Best practice for chemotherapy for treatment of breast cancer
by ariel
Andreas Makris. Mount Vernon Cancer Center. Royal ...
Andrew H. Ko, MD University of California San Francisco
by test
Gastrointestinal Oncology Program. Treatment of m...
“Critical & Terminal illness – moving to new Frontiers!”
by luanne-stotts
“How long have I got, doc?”. . -not . a ques...
Surgery for Metastatic Brain Tumor from Breast Cancer
by bella
Tanat Vaniyapong, MD. Neurosurgery Unit, Faculty o...
Efficacy of sorafenib in patients with
by caitlin
desmoid. -type . fibromatosis. Rodrigo Munhoz. 1. ...
Case Discussion A 52-year-old man initially presented with
by lois-ondreau
nonmuscle. -invasive . bladder cancer. He receive...
Btk inhibition in Mantle cell Lymphoma & CLL
by test
Simon Rule. Professor of Clinical . Haematology. ...
As it pertains to the last patient in your practice who died of metastatic nonsquamous
by kittie-lecroy
non-small cell lung cancer (NSCLC) . with no targ...
The Impending D eath of Cancer: A Herculean Task Emerging Therapies 2016
by phoebe-click
The Impending D eath of Cancer: A Herculean Task...
Immuno-Oncology Dr. Michael Palumbo
by mofferro
April 18, 2018. Immuno-Oncology. Activating the im...
A phase 3 trial comparing talazoparib, an oral PARP inhibitor, to physician’s choice of therapy
by bikersjoker
patients with . advanced breast . cancer and a ger...
Thomas E. Keane Medical University of South Carolina
by valerie
Charleston, SC. Bones, Hot Flashes, and ADT Use Wi...
Beth Sandy, MSN, CRNP Nurse Practitioner
by PriceOfFreedom
Abramson Cancer Center . University of Pennsylvani...
Vanessa A. Lukas 1 , MS4; Tim Craven
by eleanor
2. , . MSPH. ; Ashok K. Hemal. 1. , MD; Ram A. Pa...
Laparoscopic gastric cancer surgery:
by natalia-silvester
Is it time for Upper GI surgeons to follow in the...
Measuring Quality and Value in Oncology
by conchita-marotz
The Need for Measurement. Payers (Medicare and pr...